Jilei Zhang

发表

High expression levels of SMAD3 and SMAD7 at diagnosis predict poor prognosis in acute myeloid leukemia patients undergoing chemotherapy

X. Ke, Siyuan Yang, Jing Wang, 2018, Cancer Gene Therapy.

BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation

X. Ke, Siyuan Yang, Jing Wang, 2018, Annals of Hematology.

High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation

X. Ke, Siyuan Yang, Jing Wang, 2019, Cancer management and research.

CMAR_A_192845 3053..3060

X. Ke, Siyuan Yang, Jing Wang, 2019 .

MicroRNA-425 upregulation indicates better prognosis in younger acute myeloid leukemia patients undergoing chemotherapy.

X. Ke, Siyuan Yang, Jing Wang, 2019, Oncology letters.

ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation

X. Ke, Siyuan Yang, Jing Wang, 2019, Bioscience reports.

Biological and clinical influences of NPM1 in acute myeloid leukemia patients with DNMT3A mutations

X. Ke, Siyuan Yang, Jing Wang, 2018, Cancer management and research.

High ETS2 expression predicts poor prognosis in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation

X. Ke, Siyuan Yang, Jing Wang, 2018, Annals of Hematology.

Expression level of GAS6-mRNA inﬂuences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation

X. Ke, Siyuan Yang, Jing Wang, 2019 .

High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation.

X. Ke, Siyuan Yang, Jing Wang, 2019, Oncology letters.

Clinical and biological implications of IDH1/2 in acute myeloid leukemia with DNMT3Amut

X. Ke, Siyuan Yang, Jing Wang, 2018, Cancer management and research.

Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial

Ling Zhang, Ling Li, Yinling Li, 2023, Experimental Hematology & Oncology.

High Expression Levels of ACTN1 and ACTN3 Indicate Unfavorable Prognosis in Acute Myeloid Leukemia

X. Ke, Siyuan Yang, Jing Wang, 2019, Journal of Cancer.

High expression levels of SMAD3 and SMAD7 at diagnosis predict poor prognosis in acute myeloid leukemia patients undergoing chemotherapy

X. Ke, Siyuan Yang, Jing Wang, 2018, Cancer Gene Therapy.

Expression level of ACOT7 influences the prognosis in acute myeloid leukemia patients.

X. Ke, Siyuan Yang, Jing Wang, 2019, Cancer biomarkers : section A of Disease markers.